Opportunistic etiological agents causing lung infections: emerging need to transform lung-targeted delivery

SK Debnath, M Debnath, R Srivastava - Heliyon, 2022 - cell.com
Lung diseases continue to draw considerable attention from biomedical and public health
care agencies. The lung with the largest epithelial surface area is continuously exposed to …

Efficacy and safety of new and emerging drugs for COVID-19: Favipiravir and dexamethasone

S Sood, GK Bhatia, P Seth, P Kumar, J Kaur… - Current pharmacology …, 2021 - Springer
Abstract Purpose of Review The widespread respiratory disease of virus known as severe
acute respiratory syndrome–coronavirus 2019 (SAR-CoV-2) had infected more than 200 …

Potential application of bionanoparticles to treat severe acute respiratory syndrome coronavirus-2 infection

SK Debnath, R Srivastava - Frontiers in Nanotechnology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a contagious virus that
spreads exponentially across the world, resulting in serious viral pneumonia. Several …

Drugs repurposing for SARS-CoV-2: New insight of COVID-19 druggability

SK Debnath, M Debnath, R Srivastava… - Expert Review of Anti …, 2022 - Taylor & Francis
Introduction The ongoing epidemic of severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) creates a massive panic worldwide due to the absence of effective …

Coronene surface for delivery of Favipiravir: Computational approach

Y Cao, AA Rajhi, M Abedi, M Yousefi… - Inorganic Chemistry …, 2022 - Elsevier
Delivery of pharmaceutical compounds has been always an important issue to be solved by
appropriate methodologies. In this regard, coronene surface was investigated in this work for …

Development of plant-produced subunit vaccine and therapeutic protein for COVID-19

K Siriwattananon - 2021 - digital.car.chula.ac.th
Due to the rapid transmission of the Coronavirus Disease 2019 (COVID-19) causing serious
public health problems and economic burden, the development of effective therapeutic …